Source:http://linkedlifedata.com/resource/pubmed/id/16373583
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0018805,
umls-concept:C0035126,
umls-concept:C0037083,
umls-concept:C0109317,
umls-concept:C0600306,
umls-concept:C0752312,
umls-concept:C1120843,
umls-concept:C1150579,
umls-concept:C1314939,
umls-concept:C1333340,
umls-concept:C1366882,
umls-concept:C1370600,
umls-concept:C1705767,
umls-concept:C1705791,
umls-concept:C1710082
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-4-10
|
pubmed:abstractText |
We previously showed that C-phycocyanin (PC), an antioxidant biliprotein pigment of Spirulina platensis (a blue-green alga), effectively inhibited doxorubicin-induced oxidative stress and apoptosis in cardiomyocytes. Here we investigated the cardioprotective effect of PC against ischemia-reperfusion (I/R)-induced myocardial injury in an isolated perfused Langendorff heart model. Rat hearts were subjected to 30 min of global ischemia at 37 degrees C followed by 45 min of reperfusion. Hearts were perfused with PC (10 microM) or Spirulina preparation (SP, 50 mg/l) for 15 min before the onset of ischemia and throughout reperfusion. After 45 min of reperfusion, untreated (control) hearts showed a significant decrease in recovery of coronary flow (44%), left ventricular developed pressure (21%), and rate-pressure product (24%), an increase in release of lactate dehydrogenase and creatine kinase in coronary effluent, significant myocardial infarction (44% of risk area), and TdT-mediated dUTP nick end label-positive apoptotic cells compared with the preischemic state. PC or SP significantly enhanced recovery of heart function and decreased infarct size, attenuated lactate dehydrogenase and creatine kinase release, and suppressed I/R-induced free radical generation. PC reversed I/R-induced activation of p38 MAPK, Bax, and caspase-3, suppression of Bcl-2, and increase in TdT-mediated dUTP nick end label-positive apoptotic cells. However, I/R also induced activation of ERK1/2, which was enhanced by PC treatment. Overall, these results for the first time showed that PC attenuated I/R-induced cardiac dysfunction through its antioxidant and antiapoptotic actions and modulation of p38 MAPK and ERK1/2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP...,
http://linkedlifedata.com/resource/pubmed/chemical/Phycocyanin,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0363-6135
|
pubmed:author |
pubmed-author:GanesanLatha PLP,
pubmed-author:KhanMahmoodM,
pubmed-author:KuppusamyPeriannanP,
pubmed-author:KutalaVijay KumarVK,
pubmed-author:NaiduMadireddi UMU,
pubmed-author:ParinandiNarasimham LNL,
pubmed-author:ShobhaJagdish CJC,
pubmed-author:TridandapaniSusheelaS,
pubmed-author:VaradharajSaradhadeviS
|
pubmed:issnType |
Print
|
pubmed:volume |
290
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H2136-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16373583-Animals,
pubmed-meshheading:16373583-Cardiotonic Agents,
pubmed-meshheading:16373583-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:16373583-MAP Kinase Signaling System,
pubmed-meshheading:16373583-Phycocyanin,
pubmed-meshheading:16373583-Rats,
pubmed-meshheading:16373583-Rats, Sprague-Dawley,
pubmed-meshheading:16373583-Reactive Oxygen Species,
pubmed-meshheading:16373583-Reperfusion Injury,
pubmed-meshheading:16373583-Treatment Outcome,
pubmed-meshheading:16373583-p38 Mitogen-Activated Protein Kinases
|
pubmed:year |
2006
|
pubmed:articleTitle |
C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling.
|
pubmed:affiliation |
Davis Heart and Lung Research Institute, Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
|
pubmed:publicationType |
Journal Article
|